medigraphic.com
ISSN 2078-7162 (Print)

2020, Number 3

<< Back Next >>

Rev Cub de Med Fis y Rehab 2020; 12 (3)

Instruments to evaluate sequelae in post-infection patients to COVID-19. Its usefulness in rehabilitation

Seoane PJM, Rodríguez HEI, Cuellar CT, Trujillo MVD

Language: Spanish
References: 52
Page:
PDF size: 384.25 Kb.


ABSTRACT

The SARS-CoV-2 COVID-19 pandemic is affecting 185 countries. Cuba, despite the epidemiological control achieved, is not unaware of this reality. The lethality below 3.9% of this new CoV-2 and the high virulence cause the death of many patients, while in others they leave sequels that correspond to the respiratory, cardiovascular, neurological, immunological, renal, nutritional and osteomioarticular system complications. The objective is to determine the necessary tools to evaluate the intensity of post-infection sequelae SAR-CoV-2 to COVID-19. The literature was reviewed through the databases consulted for the study. Patient's severity, time of hospitalization, complications, decompensation generated by chronic noncommunicable diseases and age act as comorbidity in a patient with this disease. Among the sequelae it leaves in patients are difficulty breathing, coughing, fatigue, muscle weakness, limitations in daily activities, emotional and cognitive disorders. That is why it is urgent to have evaluation tools to accurately quantify the sequelae and create personalized treatment strategies to restore the patient's physical, psychological and social condition. Among the tools to be used for a detailed description of the sequelae and to achieve a personalized intervention are control instruments, functional respiratory tests, tests for patients with cardiovascular affectation (ergometry), assessment of walking by a functional laboratory of movement, evaluation of cognitive functions, emotions and disability.


REFERENCES

  1. Lu H, Stratton CW, Tang YW. Outbreak of Pneumonia of Unknown Etiology in Wuhan, China: the Mystery and the Miracle. J Med Virol. 2020; 92:401-2. DOI: http://10.1002/jmv.256782

  2. Wang C, Horby PW, Hayden FG, Gao GF. A novel Coronavirus Outbreak of Global Health Concern. Lancet. 2020; 395:470-3. DOI: http://10.1016/S01406736(20)30185-9

  3. Puig Meneses Y. Protocolos cubanos para tratar la COVID-19, vitales en la evolución clínica de los pacientes. Granma. 10 de julio 2020 [acceso: 10/07/2020]. Disponible en: http://www.granma.cu/cuba-covid-19/2020-07-10/protocolos-cubanos-para-tratar-la-covid-19-vitales-en-la-evolucion-clinica-de-los-pacientes-10-07-2020-00-07-01

  4. Milanés L. COVID-19: Protocolo y Bioseguridad en Cuba (+ infografías) [acceso: 02/06/2020]. Disponible en: https://www.cubahora.cu/ciencia-y-tecnologia/covid-19-protocolo-y-bioseguridad-en-cuba

  5. Protocolo Nacional MINSAP vs. COVID-19 [acceso: 20/05/2020]. Disponible en: http://www.sld.cu/anuncio/2020/05/11/ministerio-de-salud-publica-protocolo-de-actuacion-nacional-para-la-covid19

  6. Guan WJ, NiZY, Hu Y, LiangWH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; 382:1708-20. DOI: http://10.1056/NEJMoa2002032

  7. Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, et al. A Novel Coronavirus from Patients with Pneumonia in China, 2019 New England. Journal of Medicine. 2020; 382:727-33. DOI: http://10.1056/NEJMoa2001017

  8. Paniz-Mondolfi A, Bryce C, Grimes Z, Gordon RE, Reidy J, Lednicky J, et al. Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). J Med Virol. 2020. DOI: http://10.1002/jmv.25915

  9. Wong SH, Lui RN, Sung JJ. Covid-19 and the digestive system. J Gastroenterol Hepatol. 2020; 35:744-8. DOI: http://10.1111/jgh.15047

  10. Nath A. Neurologic complications of coronavirus infections. Neurology. 2020; 94:809-10. DOI: http://10.1212/WNL.0000000000009455

  11. Avula A, Nalleballe K, Narula N, Sapozhnikovc S, Dandub V, Toom S, et al. COVID-19 presenting as stroke. Brain Behav Immun. 2020; 87:115-9. DOI: http://10.1016/j.bbi.2020.04.077

  12. Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, et al. Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med. 2020; 1-3. DOI: http://10.1056/NEJMc2009191

  13. Klok FA, Kruip MJHA, van der Meer NJM, Arbousd MS, Gommerse DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020; 191:145-7. DOI: http://10.1016/j.thromres.2020.04.013

  14. Serra-Valdés M. Las enfermedades crónicas no transmisibles y la pandemia por COVID-19. Revista Finlay. 2020 [acceso: 20/07/2020]; 10(2). Disponible en: http://www.revfinlay.sld.cu/index.php/finlay/article/view/846/1870

  15. Belluck P. Así es la recuperación para muchos de los sobrevivientes de la COVID19. [acceso: 02/07/2020]. Disponible en: https://www.nytimes.com/es/2020/07/02/espanol/ciencia-ytecnologia/sobrevivientes coronavirus-recuperacion.html

  16. Feng W, Zong W, Wang F. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): a review. Mol Cancer. 2020 [acceso: 03/07/2020]. 19, 100;doi:https://doi.org/10.1186/s12943-020-01218-1

  17. Alemañy Castilla C. Secuelas de la COVID-19: ¿qué hay de cierto sobre la fibrosis pulmonar? [acceso: 22/07/2020]. Disponible en https://medium.com/juventud-t%C3%A9cnica/secuelas-de-la-covid-19-qu%C3%A9-hay-de-cierto-sobre-la-fibrosis-pulmonar-4bfc3ba0bd18

  18. Mamiko Onoda, Martínez Chamorro MJ. Grupo de Patología Infecciosa de la Asociación Española de Pediatría de Atención Primaria. Abril de 2020. Pruebas diagnósticas de laboratorio de COVID-19. [acceso: 22/07/2020]. Disponible en: https://www.aepap.org/sites/default/files/documento/archivos-adjuntos/pruebas_diagnosticas_de_laboratorio_de_covid_vfinal.pdf

  19. Carda S. The role of physical and rehabilitation medicine in the COVID-19 pandemic: The clinician’s view. Ann Phys Rehabil Med. 2020 [acceso: 22/07/2020]. DOI: https://doi.org/10.1016/j.rehab.2020.04.001

  20. Anuario Estadístico de Salud. MINSAP. 2019 [acceso: 22/07/2020]. Disponible en: https://temas.sld.cu/estadisticassalud/

  21. Rodríguez Masó S. Programa Nacional de Rehabilitación En Cuba. The International Agency for the Prevention of Blindness [acceso: 22/07/2020]. Disponible en https://www.iapb.org/news/programa-nacional-de-rehabilitacion-en-cuba/

  22. Revilla Arias H, González Mustelier D, Valenzuela Fonseca LM. Calidad de la atención de salud brindada en un servicio de rehabilitación integral de base comunitaria. MEDISAN Santiago de Cuba mar 2016. [acceso: 22/07/2020]. 20(3). Disponible en http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1029-30192016000300006

  23. Chen N, Zhou M, Dong X. Epidemiological and clinical characteristic of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptives study. The Lancet. 2020 [acceso: 27/06/2020]; 395(10223:507-13). DOI: https://doi.org/10.1016/

  24. Letter to the editor. Rehabilitation of COVID-19 patients. J Rehabil Med 2020; 52: jrm00046 Journal Compilation. DOI: https://10.2340/16501977-2678

  25. Klok FA, Kruip MJHA, van der Meer NJM, Arbousd MS, Gommerse DAMPJ, Kant KM, et al. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb Res. 2020[acceso 26/06/2020]; 191: 145-7. DOI: http://10.1016/j.thromres.2020.04.013

  26. Lu L, Yang T. Pulmonary Rehabilitaction for patients with coronavirus disease 2019(COVID-19). Review. Chronic disease and translational medicine. (2020); 6:79-86. DOI: https://doi.org/10.1016/j.cdtm.2020.05.002 2095-882

  27. Jané Larai A, Lima Abascal MI, Machado Molina D, Sánchez de la Osa RD, Arnet Calvo IM. Interpretación de las pruebas funcionales respiratorias por diagrama de flujo. Algoritmo diagnóstico. Revista Cubana de Medicina Física y Rehabilitación. 2016 [acceso: 27/06/20]; 8(1):138-42. Disponible en: http://www.revrehabilitacion.sld.cu/index.php/reh/article/view/25/202

  28. Mottram Carl. Spirometry interpretation. Mottram CD. Manual of Pulmonary Function Testing. Mayo Clinic College of Medicine, 2012 [acceso: 25/06/2020]. Chapter 6. Disponible en: https://www.elsevier.com/books/ruppels-manual-of-pulmonary-function-testing/mottram/978-0-323-08505-2

  29. Maestú Puente L, García de Pedro J. Pruebas de función respiratoria y broncoscopia, Hospital General Gregorio Marañón, Universidad Complutense de Madrid, Madrid. Las pruebas funcionales respiratorias en las decisiones clínicas. Arch Bronconeumol. 2012; 48(5):161-9. DOI: https://10.1016/j.arbres.2011.12.012

  30. Yu CM, Wong RS, Wu EB, et al. Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J. 2006 [acceso: 27/07/2020]; 82(964):140-4 DOI: https://10.1136/pgmj.2005.037515

  31. Andrenelli E, Negrini F, De Sire A, Arienti CH, Patrini M, Negrini S, et al. Systematic rapid living review on rehabilitation needs due to Covid-19: update to May 31st. 2020. European Journal of Physical and Rehabilitation Medicine. 2020 Jun 16 [acceso: 27/07/2020]; 56(3):347-53. DOI: https://10.23736/S1973-9087.20.06435-7

  32. Trilla A. Respuesta inmunitaria contra el coronavirus. Madrid: La Vanguardia. 2020 [acceso: 27/07/2020]. Disponible en: https://www.lavanguardia.com/vida/20200304/473962317182/coronavirus-respuesta-inmunitaria-experto-organismo-claves.html

  33. Zhao Y, Zhao Z, Wang Y, Zhou Y, Ma Y, Zuo W. Single-cell RNA expression profiling of ACE2, the receptor of SARS-CoV-2. bioRxiv [preprint] 2020;1-13. DOI: https://10.1101/2020.01.26.919985

  34. Rivas-Estany E, Barrera Sandey JD, Sixto-Fernández S, Rodríguez Nande LM, Kesser-García C. Programa cubano de rehabilitación cardíaca. Resultados. Rehabilitación (Madr). 2013 [acceso: 27/07/2020]. Disponible en: http://dx.doi.org/10.1016/j.rh.2013.07.003

  35. Rivas Estany E. Rehabilitation cardíaca prolongada. En: Maroto Montero JM, de Pablo Zarzosa C, editores. Rehabilitación cardiovascular. Cap. 32. Madrid: Editorial Panamericana; 2011: 463-72.

  36. Taylor RS, Brown A, Ebrahin S, Jolliffe J, Noorani H, Rees K, et al. Execive -based rehabilitation for patients with coronary heart disease: Systematic review and metanalysis of rabdomized controlled trials. Am J Med. 2004; 116(10):682-92. DOI: https://10.1016/j.amjmed.2004.01.009

  37. Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, Karim AH and Sattar A Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front. Neurol. 2020; 11:518. DOI: https://10.3389/fneur.2020.00518

  38. Mao L, Jin H, Wang M, Hu Y, Chen S, He Q, et al. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020; e201127. DOI: https://10.1001/jamaneurol.202 0.11274

  39. Sheehy L, M. Considerations for Postacute Rehabilitation for Survivors of COVID-19. JMIR Public Health Surveill. 2020; Apr-Jun; 6(2):e19462. DOI: https://10.2196/19462

  40. Haro M. Laboratorio de análisis de marcha y movimiento D. Rev. Med. Clin. Conde-2014 [acceso: 02/06/2020]; 25(2)237-47. Disponible en: https://www.clinicalascondes.cl/Dev_CLC/media/Imagenes/PDF%20revista%20médica/2014/2%20marzo/7-Dra.Haro.pdf

  41. Sutherland D, Olshen R, Cooper L, Woo S. The development of nature gait. J Bone Joint Surg 1980 [acceso: 02/06/2020]; 62(3):336-53. Disponible en: https://insights.ovid.com/pubmed?pmid=7364807

  42. Rodríguez CI. Entrenamiento robótico como medio de rehabilitación para la marcha. Evid Med Invest Salud. 2012 [acceso: 02/06/2020]; 5(2):46-54. Disponible en https://www.medigraphic.com/cgi-bin/new/resumen.cgi?IDARTICULO=3819

  43. Lee G, Pollo FE. Technology Overview: The Gait Analysis Laboratory. Journal of clinical engineering January 2001; 129-35. DOI: https://10.1097/00004669-200126020-00010

  44. Guerra J. Manual de fisioterapia. México: El manual moderno; 2004. 12.

  45. Cifuentes C, Martínez F, Romero E. Análisis teórico y computacional de la marcha normal y patológica: una revisión. Rev Facultad de Medicina en Colombia 2010; 18(2):182-96. DOI: http://10.18359/rmed.1311

  46. de Lima e Silva RR, Sabino Pinho CP, Galvão Rodrigues I, de Moura Monteiro JG. Ángulo de fase como indicador del estado nutricional y pronóstico en pacientes críticos. Nutr Hosp. 2015; 31(3):1278-85. DOI: http://dx.doi.org/10.3305/nh.2015.31.3.8014

  47. Giuseppe Sergi, De Rui M, Stubbs B, Veronese N, Manzato E. Measurement of lean body mass using bioelectrical impedance analysis: a consideration of the pros and cons. Aging Clinical and Experimental Research. 2017; 29(4):591-7. DOI: http://10.1007/s40520-016-0622-6

  48. Garzón-Orjuela N, Barrera-Perdomo MP, Gutiérrez-Sepúlveda MP, Merchán-Chaverra R, León-Avendaño AC, Aicedo-Torres LM, Hernández-Rodríguez MX. Análisis de la

  49. composición corporal mediante impedancia bioeléctrica octopolar en pacientes hospitalizados en Bogotá DC, Colombia. Estudio piloto. Rev. Fac. Med. 2019; 67(3):239-47. DOI: http://dx.doi.org/10.15446/revfacmed.v67n3

  50. de Blasio F, Di Gregorio A, de Blasio F. Malnutrition and sarcopenia assessment in patients with chronic obstructive pulmonary disease according to international diagnostic criteria, and evaluation of raw BIA variables Respiratory Medicine 2018; 134:1-5. DOI: http://10.1016/j.rmed.2017.11.006

  51. Cloetens L, Johansson-Persson A, Helgegren H, Landin-Olsson M, Uusitupa M, Akesson B, et al. Assessment of body composition in subjects with metabolic syndrome comparing single-frequency bioelectrical impedance analysis and bioelectrical spectroscopy Metabolic Syndrome and Related Disorders 2015; 13(2):91-8. DOI: http://doi.org/10.1089/met.2014.0130

  52. Ministerio de Salud Pública: nueva versión del Protocolo de Actuación Nacional para la COVID-19 [acceso: 16/08/2020]. Disponible en: https://files.sld.cu/editorhome/files/2020/08/VERSION-5-DEL-PROTOCOLO-PARA-PUBLICAR-13-DE-AGOSTO-2020.pdf




2020     |     www.medigraphic.com